What's in InVasc Therapeutics, Inc.'s pipeline?

InVasc Therapeutics, Inc. has 4 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with InVasc Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, Heart Care Foundation, Novartis, Stendhal Americas, S.A..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/invasc-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

InVasc Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

InVasc Therapeutics, Inc. pipeline: 2 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
amlodipine and olmesartan	amlodipine and olmesartan	marketed
losartan and HCTZ	losartan and HCTZ	marketed	Angiotensin II receptor blocker + thiazide diuretic combination	AT1 receptor (losartan); sodium-chloride cotransporter (HCTZ)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · 1 shared drug class
Heart Care Foundation · 1 shared drug class
Novartis · 1 shared drug class
Stendhal Americas, S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for InVasc Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). InVasc Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/invasc-therapeutics-inc. Accessed 2026-05-16.